| Brimonidine, cas# 70359-46-5 | API reference material |
| Potassium peroxymonosulfate, | Versatile oxidizing agent |
| Naftifine # 65472-88-0 | API reference material |
| N-Octylphosphonic acid, cas# 4724-48-5 | Surface coatings agent, micro/ nanotechnology |
| LiHMDS, cas# 4039-32-1 | Organic base, polymerization acceleration |
| Squalene, cas# 111-02-4 | Cosmetics, nutritional |
| Lisinopril, cas# 83915-83-7 | API reference material |
| Fosinopril, cas# 98048-97-6 | API reference material |
| Candesartan, cas# 139481-59-7 | API reference material |
| Enalapril, cas# 75847-73-3 | API reference material |
| methacrylate, cas# 3063-94-4 | Monomer |
| trans-4-Hydroxy-D-proline, cas# 3398-22-9 | Chiral building block |
| Hydroxy ethyl starch, cas# 9005-27-0 | Nonionic starch derivative, blood volume expander |
| TCEP, cas# 51805-45-9 | Reducing agent, peptide disulfide bonds |
| Methane Sulfonic acid, cas# 303-81-1 | Organic acid, pharmaceutical grade |
| Ravecarb Polycarbonate Diols | Precursor for high performance polyurethanes |
| Novobiocin acid, cas# 303-81-1 | API reference material |
| Vecuronium Bromide, cas# 50587-95-6 | API reference material |
| Ishikawa’s reagent, cas# 309-88-6 | Fuorination reagent |
| Iodine monochloride, cas# 7790-99-0 | Organic synthesis reagent |
| Tartaric acid, cas# 87-69-4 | Chiral molecule, salt |
| Cyclohexanecarbonyl chloride, cas# 2719-27-9 | Organic synthesis |
| (2S)-(+)-Glycidyl tosylate, cas# 70987-78-9 | Chiral synthesis |
| 3,4 Di Methoxy aniline, cas# 6315-89-5 | Amine building block |